MHS6 and Malignant Hyperthermia 6: Association Evidence

Gene-Disorder Association · Article

Gene

MHS6

Malignant Hyperthermia Susceptibility 6

Disorder

First reported 1993

Key publication · disorder Exclusion of malignant hyperthermia susceptibility (MHS) from a putative MHS2 locus on chromosome 17q and of the alpha 1, beta 1, and gamma subunits of the dihydropyridine receptor calcium channel as candidates for the molecular defect.Human molecular genetics · 1993

Manually curated

Association Review

In brief

The association between MHS6 (Malignant Hyperthermia Susceptibility 6) and Malignant Hyperthermia 6 is a manually-curated gene–disease association, drawing on a single expert-curated source, which records a susceptibility locus.

Sources 1

Clinical variants 0

Symptoms 0

Compounds 0

Trials 0

Publications 0

At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access

Provenance

Evidence and sources

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access

Malignant Hyperthermia 6

The disorder

5 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access

Provenance

References & sources

1 reference

Every source and publication cited across this dossier, as one numbered reference list.

Request access